Securitas

Good Q1 2025, portfolio review

08/05/25 -"Organic sales growth and operating margin improvement were in line with expectations, with all divisions contributing to the overall performance. At constant currency, sales growth in Technology and ..."

PDF page sample
Pages
45
Language
English
Published on
08/05/25
Download
You may also be interested by these reports :
09/11/25
We have taken a refreshed view of Experian’s outlook and valuation. Previously, we maintained a cautious stance due to concerns over a potential ...
07/11/25
In Q3 2025, organic sales growth slowed sequentially, reflecting the portfolio management in Europe and Ibero-America and Technology and solutions ...
06/11/25
Adecco posted better-than-expected Q3 2025 results, with organic revenue growth and EBITA margin improvement driven by Adecco GBU and LHH. Adecco GBU ...
23/10/25
BV’s Q3 revenues were slightly above the consensus in absolute terms and organic growth. Sales growth was supported by very strong growth in Marine & ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO